Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo

INTRODUCTION: Bone metastasis remains incurable with treatment restricted to palliative care. Cabozantinib (CBZ) is targeted against multiple receptor tyrosine kinases involved in tumour pathobiology, including hepatocyte growth factor receptor (MET) and vascular endothelial growth factor receptor 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone
Main Authors: Haider, Marie-Therese, Hunter, Keith D., Robinson, Simon P., Graham, Timothy J., Corey, Eva, Dear, T. Neil, Hughes, Russell, Brown, Nicola J., Holen, Ingunn
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science 2015
Assuntos:
Original Full Length Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768060/
https://ncbi.nlm.nih.gov/pubmed/26279137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2015.08.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados